Results 141 to 150 of about 26,674 (238)

A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations

Biologics: Targets & Therapy, 2014
Alvin F Wells,1,2 Nicole Jodat,1 Michael Schiff3 1Rheumatology and Immunotherapy Center, Franklin, WI, USA; 2Duke University Medical Center, Durham, NC, USA; 3University of Colorado, School of Medicine, Denver, CO, USA Abstract: There are now more ...
Wells AF, Jodat N, Schiff M
doaj  

One year in review: ultrasound in arthritis [PDF]

, 2016
Musculoskeletal ultrasound (MSUS) has become a relevant part of rheumatology practice and research because it substantially allows us to optimize management of rheumatic and musculoskeletal diseases. This non-invasive imaging modality is a valuable point-
IAGNOCCO, Annamaria, Naredo, Esperanza
core  

First-line tumor necrosis factor inhibitor versus abatacept treatment choice in real-world patients with anticitrullinated protein antibody- and rheumatoid factor-positive rheumatoid arthritis

Journal of Comparative Effectiveness Research
Aim: To compare characteristics of patients with anticitrullinated protein antibody-positive (ACPA+) and rheumatoid factor-positive (RF+) rheumatoid arthritis (RA) who initiated abatacept or a tumor necrosis factor inhibitor (TNFi) as a first-line ...
Gordon Lam, Hanke Zheng, Andrew Klink, Vardhaman Patel, Emily Bland, Laetitia N’Dri, Parisa Asgarisabet, Keith Wittstock, Cherrishe Brown-Bickerstaff, Mark Chaballa, Vadim Khaychuk, Bruce Feinberg   +11 more
doaj   +1 more source

Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritis [PDF]

, 2018
To assess the cost-effectiveness of abatacept compared to different biologic treatment strategies for moderate to severe rheumatoid arthritis based on current medical practices in Canada.
Beresniak, Ariel, Bessette, Louis, Dupont, Danielle, Haraoui, Boulos, Maclean, Ross, Rahman, Proton, Russell, Anthony, Thorne, Carter   +7 more
core  

Hypertension and its complications in a young man with autoimmune disease [PDF]

, 2017
Basile, Jan N., Batlle, Daniel C., Dhaun, Neeraj, Dominiczak, Anna F., Elijovich, Fernando, Jennings, Garry L.R., Laffer, Cheryl L., Miller-Hodges, Eve, Oliveras, Anna, Oparil, Suzanne   +9 more
core   +1 more source

Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis [PDF]

, 2018
Elmamoun, Musaab, Fabre, Aurelie, FitzGerald, Oliver, Gallagher, Phil, Gogarty, Martina, Haroon, Muhammad, Heffernan, Eric, Kelly, Genevieve, Kirby, Brian, McCormack, Janet, Mellerick, Lisa, Szentpétery, Ágnes   +11 more
core   +1 more source

Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes. [PDF]

Diabetes
Galderisi A, Carr ALJ, Taylor P, Bonet J, Cuthbertson D, Sosenko J, Sims EK, Evans-Molina C, Dalla Man C, Ismail HM, Nathan B, Petrelli A, Senior P, Sherr JL, Herold KC, Russell WE, Moran A, Dayan C.   +17 more
europepmc   +1 more source

Abatacept today, TMA away: protecting the endothelium. [PDF]

Blood Adv
Ngwube A, Abraham A.
europepmc   +1 more source

Bowenoid Actinic Keratosis in a Patient Receiving Abatacept for Rheumatoid Arthritis: A Case Report. [PDF]

Cureus
Kaga M, Amano H, Kon T, Ogura K.
europepmc   +1 more source

The Renal Activity Index for Lupus: Validation for Prediction of Kidney Inflammation in Adult Patients With Lupus Nephritis. [PDF]

J Rheumatol
O'Connor SK, Devarajan P, Liu J, Maldonado MA, Sproles A, Rose J, Thornton S, Chen C, Huang B, Brunner HI.   +9 more
europepmc   +1 more source